MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin (2003)

Peer-Reviewed Study · Roulet A, Puel O, Gesta S, Lepage JF, Drag M, Soll M, et al. · January 2003

Roulet A et al., 2003-01: Genetic study of ivermectin-sensitive Collies identifying a homozygous four-base-pair deletion in the canine MDR1 gene and no detectable P-glycoprotein in affected dogs. It is the veterinary counterpart of the mouse knockout and the basis of MDR1 breed testing.

The corresponding transcripts from ivermectin-sensitive Collies revealed a homozygous 4-bp exonic deletion.

Roulet A et al., 2003-01: Genetic study of ivermectin-sensitive Collies identifying a homozygous four-base-pair deletion in the canine MDR1 gene and no detectable P-glycoprotein in affected dogs. It is the veterinary counterpart of the mouse knockout and the basis of MDR1 breed testing. C4 mechanism (veterinary). Study type: genetic/case-control laboratory study in dogs (Collies vs Beagle reference); N not stated in the abstract; France. Dose: not applicable (genotype study of dogs reported as ivermectin-hypersensitive). Comparator: wild-type Beagle P-glycoprotein cDNA. Funder and declared conflicts: not in the PubMed record. The abstract notes ivermectin 'abnormally accumulates in the brain of transgenic mice lacking the P-glycoprotein, resulting in neurotoxicity' and that enhanced sensitivity had been reported in Collies. Study type: animal.